Covid vaccine stock
![]() |
covid vaccine stocks |
corinne cardina: Keith let us talk about the 3 main stocks of covid 19 to buy from December let us talk about them and what kind of investors should be able to buy one of them.
Obviously, Pfizer is going to make billions of dollars from this vaccine. They won't pocket all the money, they do have a partner, BioNTech, German biotech that they teamed up with. But I think the COVID vaccine is going to be a big success story for Pfizer, but it's not Pfizer's only success story.
Pfizer has a strong lineup of products, that many blockbusters in their lineup that are performing quite well. Pfizer recently spun off its Upjohn unit and merged it with Mylan to form a new company, Viatris. That's actually a good move, I think for Pfizer because it removed some older drugs that were losing market share, declining sales, moved those drugs out of Pfizer's lineup and left Pfizer with a stable and pretty strong products as well as some pretty promising pipeline.
Now, if you're a more aggressive investor, Pfizer might not be your cup of tea. They're not going to generate just outstanding growth. But I pointed out Novavax . You can put the ticker out there for our viewers, it's NVAX.
Finally, Corinne, I focused on super-aggressive investors. These are the folks who really like to gamble. The stock I mentioned for those types of investors is Arcturus Therapeutics . Yeah, you got the ticker there, ARCT. hope you understand what I am talking about.
Corinne Cardina: Definitely. Thank you so much. A lot to think about there. Some good ideas.
tell us what do you think about that situation?
0 Comments
if you have any question just let me know.